AVANTAX INC (AVTA)

US0952291005 - Common Stock

25.99  -0.01 (-0.04%)

After market: 25.995 +0.01 (+0.02%)

Fundamental Rating

3

AVTA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 219 industry peers in the Capital Markets industry. AVTA has only an average score on both its financial health and profitability. AVTA has a expensive valuation and it also scores bad on growth.



4

1. Profitability

1.1 Basic Checks

In the past year AVTA was profitable.
In the past year AVTA has reported a negative cash flow from operations.
Of the past 5 years AVTA 4 years were profitable.
In the past 5 years AVTA always reported a positive cash flow from operatings.

1.2 Ratios

With an excellent Return On Assets value of 45.03%, AVTA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
AVTA's Return On Equity of 92.10% is amongst the best of the industry. AVTA outperforms 99.51% of its industry peers.
AVTA has a Return On Invested Capital of 1.93%. This is in the lower half of the industry: AVTA underperforms 77.56% of its industry peers.
Industry RankSector Rank
ROA 45.03%
ROE 92.1%
ROIC 1.93%
ROA(3y)4.04%
ROA(5y)4.29%
ROE(3y)-16.98%
ROE(5y)-7.03%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AVTA's Profit Margin of 50.96% is amongst the best of the industry. AVTA outperforms 88.78% of its industry peers.
In the last couple of years the Profit Margin of AVTA has grown nicely.
AVTA has a Operating Margin of 2.47%. This is amonst the worse of the industry: AVTA underperforms 82.44% of its industry peers.
AVTA has a worse Gross Margin (39.67%) than 68.78% of its industry peers.
AVTA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.47%
PM (TTM) 50.96%
GM 39.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y111.12%
PM growth 5Y64.1%
GM growth 3Y-12.41%
GM growth 5Y-8.45%

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, AVTA has less shares outstanding
Compared to 5 years ago, AVTA has more shares outstanding
AVTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of 1.06, we must say that AVTA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.06, AVTA is in line with its industry, outperforming 53.66% of the companies in the same industry.
A Debt/Equity ratio of 0.62 indicates that AVTA is somewhat dependend on debt financing.
The Debt to Equity ratio of AVTA (0.62) is better than 65.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Altman-Z 1.06
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

AVTA has a Current Ratio of 2.07. This indicates that AVTA is financially healthy and has no problem in meeting its short term obligations.
AVTA has a Current ratio of 2.07. This is in the better half of the industry: AVTA outperforms 68.78% of its industry peers.
A Quick Ratio of 2.07 indicates that AVTA has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.07, AVTA is doing good in the industry, outperforming 68.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 2.07

2

3. Growth

3.1 Past

AVTA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -99.36%.
The Earnings Per Share has been growing slightly by 3.94% on average over the past years.
AVTA shows a strong growth in Revenue. In the last year, the Revenue has grown by 63.81%.
Measured over the past years, AVTA shows a small growth in Revenue. The Revenue has been growing by 5.51% on average per year.
EPS 1Y (TTM)-99.36%
EPS 3Y-4.51%
EPS 5Y3.94%
EPS Q2Q%80%
Revenue 1Y (TTM)63.81%
Revenue growth 3Y-2.45%
Revenue growth 5Y5.51%
Sales Q2Q%16.55%

3.2 Future

Based on estimates for the next years, AVTA will show a very negative growth in Earnings Per Share. The EPS will decrease by -30.17% on average per year.
Based on estimates for the next years, AVTA will show a decrease in Revenue. The Revenue will decrease by -5.38% on average per year.
EPS Next Y-76.46%
EPS Next 2Y-30.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-17.5%
Revenue Next 2Y-5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 2599.00, which means the current valuation is very expensive for AVTA.
Compared to the rest of the industry, the Price/Earnings ratio of AVTA indicates a rather expensive valuation: AVTA more expensive than 86.34% of the companies listed in the same industry.
AVTA is valuated expensively when we compare the Price/Earnings ratio to 30.85, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 29.29, the valuation of AVTA can be described as expensive.
74.15% of the companies in the same industry are cheaper than AVTA, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.48, AVTA is valued a bit more expensive.
Industry RankSector Rank
PE 2599
Fwd PE 29.29

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AVTA is valued a bit cheaper than the industry average as 61.46% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.11

4.3 Compensation for Growth

A cheap valuation may be justified as AVTA's earnings are expected to decrease with -30.17% in the coming years.
PEG (NY)N/A
PEG (5Y)659.11
EPS Next 2Y-30.17%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AVTA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AVANTAX INC

NASDAQ:AVTA (11/27/2023, 8:00:01 PM)

After market: 25.995 +0.01 (+0.02%)

25.99

-0.01 (-0.04%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap956.69M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 2599
Fwd PE 29.29
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)659.11
Profitability
Industry RankSector Rank
ROA 45.03%
ROE 92.1%
ROCE
ROIC
ROICexc
ROICexgc
OM 2.47%
PM (TTM) 50.96%
GM 39.67%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.07
Quick Ratio 2.07
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-99.36%
EPS 3Y-4.51%
EPS 5Y
EPS Q2Q%
EPS Next Y-76.46%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)63.81%
Revenue growth 3Y-2.45%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y